SEEL / Seelos Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Seelos Therapeutics, Inc.
US ˙ OTCPK
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Deler fremragende 1,362,879 shares
Insideraktier22.849.770 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Seelos Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SEEL / Seelos Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-12-01 Mehra Raj 75.757 1,3200 6.313 15,8400 99.999 3 15.68 -1.011 -1,01
2023-11-30 Golembiewski Michael Joseph 83.000 1,2075 6.917 14,4900 100.222
2022-06-01 O'Connor Daniel 16.000 0,6118 889 11,0124 9.789
2022-05-26 DALESANDRO MARGARET 35.000 0,5990 1.944 10,7820 20.965
2022-03-31 Mehra Raj 66.667 0,8526 3.704 15,3468 56.840
2020-02-13 Mehra Raj 133.333 0,7500 7.407 13,5000 100.000
2017-08-31 DENNER ALEXANDER J 6.104 1,6300 6.104 1,6300 9.950

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SEEL / Seelos Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SEEL / Seelos Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-01-03 Oppenheim Leonard A 15.212 2,4933 15.212 2,4933 37.928 730

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SEEL / Seelos Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-03-01 2024-02-29 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 1,0970 417 0 86.869
2023-12-01 2023-12-01 4 Mehra Raj SEEL Common Stock P - Purchase D 1,3200 75.757 100 185.142
2023-12-01 2023-11-30 4 Golembiewski Michael Joseph SEEL Common Stock P - Purchase D 1,2075 83.000 100 86.450
2023-09-01 2023-08-31 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0,6180 12.500 8 103.487
2023-03-02 2023-02-28 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0,6720 12.500 8 90.987
2022-06-02 2022-06-01 4 O'Connor Daniel SEEL Common Stock P - Purchase D 0,6118 16.000 10 16.000
2022-05-27 2022-05-26 4 DALESANDRO MARGARET SEEL Common Stock P - Purchase D 0,5990 35.000 21 35.000
2022-03-31 2022-03-31 4 Mehra Raj SEEL Common Stock P - Purchase D 0,8526 66.667 57 3.281.546
2022-03-04 2022-02-28 4 Golembiewski Michael Joseph SEEL Common Stock A - Award D 0,9010 12.500 11 78.487
2022-01-11 2022-01-10 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1,46 1.300.000 1.300.000
2022-01-11 2022-01-10 4 Golembiewski Michael Joseph SEEL Stock Option (right to buy) A - Award D 1,46 500.000 500.000
2022-01-06 2022-01-05 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1,56 35.000 35.000
2022-01-06 2022-01-05 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1,56 35.000 35.000
2022-01-06 2022-01-05 4 DALESANDRO MARGARET SEEL Stock Option (right to buy) A - Award D 1,56 35.000 35.000
2022-01-06 2022-01-05 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1,56 35.000 35.000
2021-09-02 2021-09-01 4 DALESANDRO MARGARET SEEL Stock Option (right to buy) A - Award D 2,16 42.000
2021-09-02 3 Golembiewski Michael Joseph SEEL Common Stock D 65.987
2021-03-17 2021-03-15 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 4,31 1.150.000 1.150.000
2021-01-08 2021-01-06 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 1,35 16.000 16.000
2021-01-08 2021-01-06 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1,35 16.000 16.000
2021-01-08 2021-01-06 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1,35 16.000 16.000
2021-01-08 2021-01-06 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1,35 16.000 16.000
2020-06-12 2020-06-11 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1,08 2.282.262 2.282.262
2020-05-15 2020-05-15 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 0,97 16.000 16.000
2020-05-15 2020-05-15 4 Dunn Judith SEEL Stock Option (right to buy) A - Award D 0,97 24.000 24.000
2020-02-14 2020-02-13 4 Mehra Raj SEEL Common Stock P - Purchase D 0,7500 133.333 100 3.214.879
2020-01-07 2020-01-06 4 Mehra Raj SEEL Stock Option (right to buy) A - Award D 1,42 731.000 731.000
2020-01-07 2020-01-06 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 1,42 16.000 16.000
2020-01-07 2020-01-06 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 1,42 16.000 16.000
2020-01-07 2020-01-06 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 1,42 16.000 16.000
2020-01-07 2020-01-06 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 1,42 16.000 16.000
2019-03-21 2019-03-20 4 Pascoe Richard W SEEL Stock Option (right to buy) A - Award D 2,33 16.000 16.000
2019-03-21 2019-03-20 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 2,33 16.000 16.000
2019-03-21 2019-03-20 4 O'Connor Daniel SEEL Stock Option (right to buy) A - Award D 2,33 24.000 24.000
2019-03-21 2019-03-20 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 2,33 16.000 16.000
2019-03-21 2019-03-20 4 Lian Brian SEEL Stock Option (right to buy) A - Award D 2,33 24.000 24.000
2019-03-21 2019-03-20 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 2,33 16.000 16.000
2019-03-21 2019-03-20 4 Smith Robin L SEEL Stock Option (right to buy) A - Award D 2,33 24.000 24.000
2019-01-28 2019-01-24 4 Mehra Raj SEEL Common Stock A - Award D 3.081.546 3.081.546
2019-01-24 2019-01-23 4 Morton Neil APRI Common Stock F - Taxes D 0,2265 -32.705 -7 100.158
2019-01-24 2019-01-23 4 Pascoe Richard W APRI Common Stock F - Taxes D 0,2265 -44.810 -10 155.396
2018-11-30 2018-11-30 4 Pascoe Richard W APRI Common Stock F - Taxes D 0,3060 -17.290 -5 200.206
2018-11-30 2018-11-30 4 Morton Neil APRI Common Stock F - Taxes D 0,3060 -12.968 -4 132.863
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 D 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-27 3 Boyd Steven APRI Common Stock, par value $.001 I 18.400.000
2018-09-04 2018-08-30 4 Dorsey Brian APRI Common Stock F - Taxes D 0,3300 -43.225 -14 115.891
2018-09-04 2018-08-30 4 Dorsey Brian APRI Common Stock M - Exercise D 81.775 159.116
2018-03-23 2018-03-21 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock J - Other I 0,71 653.409 653.409
2018-03-23 2018-03-21 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock J - Other I 0,71 -653.409 0
2018-01-08 2018-01-04 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2,11 50.000 50.000
2018-01-08 2018-01-04 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2,11 35.000 35.000
2018-01-08 2018-01-04 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2,11 35.000 35.000
2018-01-08 2018-01-04 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 2,11 35.000 35.000
2018-01-08 2018-01-04 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 2,11 35.000 35.000
2018-01-03 2018-01-03 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2,11 245.000 245.000
2018-01-03 2018-01-01 4 Pascoe Richard W APRI Common Stock F - Taxes D 1,8400 -7.679 -14 217.496
2018-01-03 2018-01-03 4 Morton Neil APRI Stock Option (right to buy) A - Award D 2,11 60.000 60.000
2018-01-03 2018-01-01 4 Morton Neil APRI Common Stock F - Taxes D 1,8400 -2.194 -4 145.831
2018-01-03 2018-01-03 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 2,11 60.000 60.000
2018-01-03 2018-01-01 4 Dorsey Brian APRI Common Stock F - Taxes D 1,8400 -5.485 -10 159.116
2017-09-07 2017-09-05 4 Morton Neil APRI Common Stock F - Taxes D 1,5600 -14.093 -22 148.025
2017-09-07 2017-09-05 4 Pascoe Richard W APRI Common Stock F - Taxes D 1,5600 -18.790 -29 225.175
2017-09-07 2017-09-05 4 Dorsey Brian APRI Common Stock F - Taxes D 1,5600 -14.093 -22 164.601
2017-09-01 2017-08-31 4 DENNER ALEXANDER J See footnotes APRI Warrants to purchase Common Stock P - Purchase I 8,80 2.835 672.453
2017-09-01 2017-08-31 4 DENNER ALEXANDER J See footnotes APRI Common Stock P - Purchase I 1,6300 6.104 10 1.447.906
2017-06-05 2017-06-01 4 Pascoe Richard W APRI Common Stock A - Award D 100.000 243.965
2017-06-05 2017-06-01 4 Dorsey Brian APRI Common Stock A - Award D 75.000 178.694
2017-06-05 2017-06-01 4 Morton Neil APRI Common Stock A - Award D 75.000 162.118
2017-03-24 2017-02-15 4 Pascoe Richard W APRI Common Stock F - Taxes D 2,7800 -3.712 -10 143.965
2017-03-24 2017-02-15 4 Morton Neil APRI Common Stock F - Taxes D 2,7800 -831 -2 87.118
2017-03-24 2017-02-15 4 Dorsey Brian APRI Common Stock F - Taxes D 2,7800 -1.495 -4 103.694
2017-01-06 2017-01-05 4 MAIER PAUL V APRI Common Stock A - Award D 11.250 13.854
2017-01-06 2017-01-05 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 11.250 15.373
2017-01-06 2017-01-05 4 SMITH SANDFORD D APRI Common Stock A - Award D 11.250 16.160
2017-01-06 2017-01-05 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 15.000 24.575
2017-01-06 2017-01-05 4 Pascoe Richard W APRI Common Stock A - Award D 100.000 147.677
2017-01-06 2017-01-05 4 Dorsey Brian APRI Common Stock A - Award D 75.000 105.189
2017-01-06 2017-01-05 4 Ray Rusty APRI Common Stock A - Award D 11.250 16.955
2017-01-06 2017-01-05 4 Morton Neil APRI Common Stock A - Award D 75.000 87.949
2016-10-03 2016-09-30 4 MAIER PAUL V APRI Common Stock A - Award D 0,3383 10.715 4 26.039
2016-10-03 2016-09-30 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0,3383 8.868 3 41.228
2016-10-03 2016-09-30 4 SMITH SANDFORD D APRI Common Stock A - Award D 0,3383 9.607 3 49.093
2016-10-03 2016-09-30 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0,3383 16.997 6 95.746
2016-10-03 2016-09-30 4 Ray Rusty APRI Common Stock A - Award D 0,3383 10.161 3 57.045
2016-07-01 2016-06-30 4 MAIER PAUL V APRI Common Stock A - Award D 0,3995 9.074 4 15.324
2016-07-01 2016-06-30 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0,3995 7.510 3 32.360
2016-07-01 2016-06-30 4 SMITH SANDFORD D APRI Common Stock A - Award D 0,3995 8.136 3 39.486
2016-07-01 2016-06-30 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0,3995 14.393 6 78.749
2016-07-01 2016-06-30 4 Ray Rusty APRI Common Stock A - Award D 0,3995 8.605 3 46.884
2016-05-20 2016-04-25 4/A Dorsey Brian APRI Common Stock A - Award D 0 51.891
2016-05-20 2016-04-25 4/A Morton Neil APRI Common Stock A - Award D 0 29.496
2016-05-20 2016-04-25 4/A Bovenizer Catherine APRI Common Stock A - Award D 0 34.594
2016-05-20 2016-05-20 4 Dorsey Brian APRI Common Stock A - Award D 250.000 301.891
2016-05-20 2016-05-20 4 Bovenizer Catherine APRI Common Stock A - Award D 50.000 34.594
2016-05-20 2016-05-20 4 Morton Neil APRI Common Stock A - Award D 100.000 129.496
2016-04-27 2016-04-25 4 Pascoe Richard W APRI Common Stock A - Award D 350.000 476.778
2016-04-27 2016-04-25 4 Dorsey Brian APRI Common Stock A - Award D 250.000 301.891
2016-04-27 2016-04-25 4 Bovenizer Catherine APRI Common Stock A - Award D 50.000 84.594
2016-04-27 2016-04-25 4 Morton Neil APRI Common Stock A - Award D 100.000 129.496
2016-04-07 2016-04-05 4 MAIER PAUL V APRI Common Stock A - Award D 0,5800 6.250 4 6.250
2016-04-07 2016-04-05 4 WIERENGA WENDALL Wierenga Family Trust APRI Common Stock A - Award I 0,5800 4.850 3 24.850
2016-04-07 2016-04-05 4 SMITH SANDFORD D APRI Common Stock A - Award D 0,5800 4.850 3 31.350
2016-04-07 2016-04-05 4 XANTHOPOULOS KLEANTHIS G By Kleanthis and Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock A - Award I 0,5800 8.621 5 64.356
2016-04-07 2016-04-05 4 Ray Rusty APRI Common Stock A - Award D 0,5800 5.927 3 38.279
2016-04-05 3 Morton Neil APRI Common Stock D 58.992
2016-04-05 3 Morton Neil APRI Common Stock D 58.992
2016-04-05 2016-04-01 4 Morton Neil APRI Stock Option (right to buy) A - Award D 0,57 165.000 165.000
2016-03-17 2016-03-15 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1,11 500.000 500.000
2016-03-17 2016-03-15 4 Pascoe Richard W APRI Common Stock A - Award D 79.778 126.778
2016-03-17 2016-03-15 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1,11 200.000 200.000
2016-03-17 2016-03-15 4 Dorsey Brian APRI Common Stock A - Award D 41.891 51.891
2016-03-17 2016-03-15 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1,11 200.000 200.000
2016-03-17 2016-03-15 4 Troupin Barbara APRI Common Stock A - Award D 43.918 43.918
2016-03-17 2016-03-15 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1,11 85.000 85.000
2016-03-17 2016-03-15 4 Bovenizer Catherine APRI Common Stock A - Award D 34.594 34.594
2016-03-07 2016-03-03 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock P - Purchase I 0,88 3.323.864 6.724.525
2016-03-07 2016-03-03 4 DENNER ALEXANDER J APRI Common Stock P - Purchase I 0,8800 6.647.728 5.850 14.479.053
2016-01-14 2016-01-12 4 DENNER ALEXANDER J APRI Warrants to Purchase Common Stock P - Purchase I 0,88 653.409 3.400.661
2016-01-14 2016-01-12 4 DENNER ALEXANDER J APRI Common Stock P - Purchase I 0,8800 1.306.819 1.150 7.831.324
2016-01-05 2016-01-04 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 0,97 25.000 25.000
2016-01-05 2016-01-04 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 0,97 25.000 25.000
2016-01-05 2016-01-04 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 0,97 50.000 50.000
2016-01-05 2016-01-04 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 0,97 25.000 25.000
2016-01-05 2016-01-04 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 0,97 25.000 25.000
2016-01-05 2016-01-04 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 0,97 25.000 25.000
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13.049.010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13.049.010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13.049.010
2015-02-23 3 Sarissa Capital Domestic Fund LP APRI Common Stock I 13.049.010
2015-01-30 2015-01-29 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1,43 150.000 150.000
2015-01-30 2015-01-29 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 1,43 300.000 300.000
2015-01-30 2015-01-29 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1,43 50.000 50.000
2015-01-30 2015-01-29 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1,43 30.000 30.000
2015-01-30 2015-01-29 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1,43 50.000 50.000
2015-01-26 2015-01-02 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 1,20 25.000 25.000
2015-01-26 2015-01-02 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 1,20 25.000 25.000
2015-01-26 2015-01-02 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 1,20 25.000 25.000
2015-01-26 2015-01-02 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 1,20 25.000 25.000
2015-01-26 2015-01-02 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 1,20 50.000 50.000
2015-01-26 2015-01-02 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 1,20 25.000 25.000
2015-01-12 2015-01-12 4 Bovenizer Catherine APRI Stock Option (right to buy) A - Award D 1,52 150.000 150.000
2014-12-30 2014-12-29 4 Dorsey Brian APRI Common Stock P - Purchase D 1,0481 10.000 10 10.000
2014-12-22 2014-12-22 4 Pascoe Richard W APRI Common Stock P - Purchase D 1,0217 10.000 10 47.000
2014-12-15 2014-12-12 4 Troupin Barbara APRI Stock Option (right to buy) A - Award D 1,16 300.000 300.000
2014-12-02 2014-12-01 4 Dorsey Brian APRI Stock Option (right to buy) A - Award D 1,13 300.000 300.000
2014-10-24 2014-10-22 4 Ray Rusty APRI Common Stock P - Purchase D 1,4999 3.500 5 32.352
2014-10-24 2014-10-22 4 Pascoe Richard W APRI Common Stock P - Purchase D 1,5100 12.000 18 37.000
2014-10-24 2014-10-23 4 SMITH SANDFORD D APRI Common Stock P - Purchase D 1,5933 18.200 29 26.500
2014-10-24 2014-10-22 4 SMITH SANDFORD D APRI Common Stock P - Purchase D 1,5242 8.300 13 8.300
2014-10-24 2014-10-22 4 WIERENGA WENDALL APRI Common Stock P - Purchase D 1,5182 20.000 30 20.000
2014-08-12 2014-08-08 4 SMITH SANDFORD D APRI Stock Option (right to buy) A - Award D 1,95 85.000 85.000
2014-03-11 2014-03-10 4 WIERENGA WENDALL APRI Stock Option (right to buy) A - Award D 2,40 100.000 100.000
2014-02-24 2014-02-20 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,38 71.000 71.000
2014-02-24 2014-02-20 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2,38 177.500 177.500
2014-02-24 2014-02-20 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2,38 31.950 31.950
2014-02-10 2014-02-06 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2,36 9.000 9.000
2014-02-10 2014-02-06 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2,36 34.000 34.000
2014-02-10 2014-02-06 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2,36 9.000 9.000
2014-02-10 2014-02-06 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,36 75.000 75.000
2014-02-10 2014-02-06 4 Pascoe Richard W APRI Stock Option (right to buy) A - Award D 2,36 157.808 157.808
2014-02-10 2013-12-30 4 Pascoe Richard W APRI Common Stock G - Gift D -10.000 25.000
2014-02-10 2014-02-06 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2,36 9.000 9.000
2014-02-10 2014-02-06 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2,36 50.000 50.000
2014-02-10 2014-02-06 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2,36 9.000 9.000
2014-01-06 2014-01-02 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2,59 16.000 16.000
2014-01-06 2014-01-02 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2,59 16.000 16.000
2014-01-06 2014-01-03 4 Oppenheim Leonard A APRI Common Stock S - Sale D 2,4933 -15.212 -38 20.449
2014-01-06 2014-01-02 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2,59 16.000 16.000
2014-01-06 2014-01-02 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2,59 16.000 16.000
2014-01-06 2014-01-02 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2,59 16.000 16.000
2013-12-27 2013-12-26 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylene Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2,5500 -17.184 -44 55.735
2013-06-21 2013-06-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2,5200 -2.864 -7 72.919
2013-05-24 2013-05-23 4 Martin Steven Robert APRI Common Stock Warrant P - Purchase D 3,40 2,8500 20.000 57 20.000
2013-05-24 2013-05-23 4 Martin Steven Robert APRI Common Stock P - Purchase D 2,8500 20.000 57 20.000
2013-05-24 2013-05-23 4 Pascoe Richard W APRI Common Stock Warrant P - Purchase D 3,40 2,8500 35.000 100 35.000
2013-05-24 2013-05-23 4 Pascoe Richard W APRI Common Stock P - Purchase D 2,8500 35.000 100 35.000
2013-05-24 2013-05-23 4 Ray Rusty APRI Common Stock Warrant P - Purchase D 3,40 2,8500 5.000 14 5.000
2013-05-24 2013-05-23 4 Ray Rusty APRI Common Stock P - Purchase D 2,8500 5.000 14 28.852
2013-05-23 2013-05-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 3,3564 -2.864 -10 75.783
2013-04-22 2013-04-22 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2,6270 -2.864 -8 78.647
2013-04-01 2013-03-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,68 1.371 1.371
2013-03-21 2013-03-21 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011 APRI Common Stock S - Sale I 2,5000 -2.864 -7 81.511
2013-02-28 2013-02-28 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,67 2.500 2.500
2013-02-01 2013-01-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,64 2.500 2.500
2013-01-08 2013-01-07 4 MAIER PAUL V APRI Stock Option (right to buy) A - Award D 2,10 16.000 16.000
2013-01-08 2013-01-07 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 2,10 16.000 16.000
2013-01-08 2013-01-07 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 2,10 16.000 16.000
2013-01-08 2013-01-07 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 2,10 16.000 16.000
2013-01-08 2013-01-07 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 2,10 16.000 16.000
2012-12-31 2012-12-31 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 1,99 2.500 2.500
2012-12-20 2012-12-18 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,04 75.000 75.000
2012-12-20 2012-12-18 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 2,04 27.500 27.500
2012-12-20 2012-12-18 4 Berholtz Randy APRI Stock Option (right to buy) A - Award D 2,04 55.000 55.000
2012-11-30 2012-11-30 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 2,20 2.083 2.083
2012-10-01 2012-09-28 4 XANTHOPOULOS KLEANTHIS G By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 09/30/2011 APRI Common Stock S - Sale I 3,2506 -3.125 -10 84.375
2012-08-23 2012-08-23 4 Damaj Bassam APRI Common Stock O - Other D 249.002 1.610.987
2012-08-23 2012-08-21 4 Damaj Bassam APRI Common Stock P - Purchase D 2,7700 760 2 1.611.747
2012-08-22 2012-08-20 4 Cox Edward M. APRI Common Stock P - Purchase D 2,7270 1.500 4 158.541
2012-08-21 2012-08-20 4 Damaj Bassam APRI Common Stock P - Purchase D 2,6895 1.500 4 1.361.985
2012-08-17 2012-08-15 4 XANTHOPOULOS KLEANTHIS G APRI Common Stock S - Sale D 3,0147 -12.500 -38 87.500
2012-08-17 2012-08-17 4 Ray Rusty APRI Common Stock P - Purchase D 2,8109 4.000 11 23.852
2012-06-05 2012-06-01 4 MAIER PAUL V APRI Director Stock Option (right to buy) A - Award D 2,60 25.000 25.000
2012-03-28 2011-06-14 4 Cox Edward M. APRI Common Stock J - Other D 13.574 157.041
2012-03-28 2011-06-14 4 Damaj Bassam APRI Common Stock J - Other D 90.167 535.040
2012-03-28 2011-06-14 4 Damaj Bassam APRI Common Stock J - Other D 34.342 825.445
2012-03-07 2012-03-05 4 Martin Steven Robert APRI Stock Option (right to buy) A - Award D 3,23 195.000 195.000
2012-03-07 2012-03-05 4 Cox Edward M. APRI Stock Option (right to buy) A - Award D 3,23 20.000 20.000
2012-03-07 2012-03-05 4 Damaj Bassam APRI Stock Option (right to buy) A - Award D 3,23 200.000 200.000
2012-03-07 2012-03-05 4 Berholtz Randy APRI Stock Option (right to buy) A - Award D 3,23 183.500 183.500
2012-01-04 2012-01-03 4 XANTHOPOULOS KLEANTHIS G APRI Stock Option (right to buy) A - Award D 5,13 16.000 16.000
2012-01-04 2012-01-03 4 Oppenheim Leonard A APRI Stock Option (right to buy) A - Award D 5,13 16.000 16.000
2012-01-04 2012-01-03 4 Oppenheim Leonard A APRI Common Stock A - Award D 5,1300 2.784 14 33.995
2012-01-04 2012-01-03 4 Gillespie Deirdre APRI Stock Option (right to buy) A - Award D 5,13 16.000 16.000
2012-01-04 2012-01-03 4 Gillespie Deirdre APRI Common Stock A - Award D 5,1300 2.784 14 15.433
2012-01-04 2012-01-03 4 ESBER HENRY JEMIL APRI Stock Option (right to buy) A - Award D 5,13 16.000 16.000
2012-01-04 2012-01-03 4 ESBER HENRY JEMIL APRI Common Stock A - Award D 5,1300 2.505 13 609.217
2012-01-04 2012-01-03 4 Ray Rusty APRI Stock Option (right to buy) A - Award D 5,13 16.000 16.000
2012-01-04 2012-01-03 4 Ray Rusty APRI Common Stock A - Award D 5,1300 2.784 14 19.852
2010-01-13 2010-01-11 4 Damaj Bassam By wife NEXM Common Stock A - Award I 0,1680 204.657 34 593.090
2010-01-13 2010-01-11 4 Damaj Bassam NEXM Common Stock A - Award D 0,1680 485.443 82 1.406.804
2010-01-13 2010-01-11 4 Crea Roberto NEXM Common Stock A - Award D 0,1680 10.233 2 29.655
2010-01-13 2010-01-11 4 ESBER HENRY JEMIL By Wife NEXM Common Stock A - Award I 0,1680 120.386 20 348.876
2010-01-13 2010-01-11 4 ESBER HENRY JEMIL NEXM Common Stock A - Award D 0,1680 234.753 39 680.309
2007-02-02 3 Tierney David S NEXM Common Stock D 18.200
2004-11-03 3 Oppenheim Leonard A Through the Trust NEXM Common Stock I 104.402
2004-11-03 3 Oppenheim Leonard A Through the IRA NEXM Common Stock I 60.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista